A Phase Ⅲ Clinical Study of SNA02-48 Injection
NCT07633119 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2026-06-08
Summary
The primary objective of this clinical trial is to compare the efficacy and safety of SNA02-48 injection with Human Tetanus Immunoglobulin (HTIG) for tetanus prophylaxis.
Conditions
- Tetanus
Interventions
- DRUG
-
SNA02-48
IM gluteal injection
- DRUG
-
Human tetanus immunoglobulin (HTIG)
IM gluteal injection
Sponsors & Collaborators
-
Sinovac Life Sciences Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-28
- Primary Completion
- 2027-03-31
- Completion
- 2027-05-31
Countries
- China
Study Locations
More Related Trials
-
A Study of Tetanus Antibody of Healthy Adults
NCT07724379 ·Status: COMPLETED
-
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
NCT07112144 ·Status: RECRUITING ·Phase: PHASE3
-
Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine
NCT07418372 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults
NCT02361866 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects
NCT02587520 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multicenter Study of Tetanus Patients in Fujian Province of China
NCT04165928 ·Status: COMPLETED
-
Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .
NCT04099303 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)
NCT07492303 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
NCT06056050 ·Status: COMPLETED ·Phase: PHASE1
-
Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children
NCT02139228 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
NCT05091619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine
NCT04989465 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine
NCT00452686 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Safety and Primary Immunogenicity of Cell-free (Three-component) Combination Vaccine for Phase I Immunogenicity in Children and Infants
NCT05189548 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
NCT04238975 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)
NCT00092469 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
NCT01529645 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
NCT06344065 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP
NCT04054882 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine
NCT06817187 ·Status: COMPLETED ·Phase: PHASE3
-
Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine
NCT06857370 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People
NCT06044077 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine
NCT01262924 ·Status: COMPLETED ·Phase: PHASE3
-
Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose
NCT01119625 ·Status: COMPLETED ·Phase: PHASE3